BBlogFlow

Operationalization in action at the new Weyburn General Hospital - SaskHealthAuthority

·Aug 26, 2026
Source: SaskHealthAuthority
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. SaskHealthAuthority

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

PAHC Weyburn celebrates Animal Health Week with open house - DiscoverWeyburn

Prairie Animal Health Centre (PAHC) in Weyburn marked Animal Health Week with an open house on Tuesday, Oct. 6. Visitors were able to tour the new facility, which opened in January. Younger visitors could also bring their stuffed animals to stations where they could give them a "vet checkup. "

DiscoverWeyburn·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·